The interest in COVID-19 vaccines has exceeded the expectations of all involved, but there is presently a clear shortage of available doses – stated the renowned propagandist and wellness supporter Agnieszka Szuster-Ciesielska, referring to the availability of Nuvaxovid. By the way, we remind all naive people that their products according to the maker "protect" against variant XBB 1.5 (craken), and now the Pirola variant is supposedly raging.
As of 6 December this year, any individual who has reached 12 years of age has the chance to receive an updated vaccine against COVID-19, namely Nuvaxovid, created by Novavax, directed against the suboption Omicron XBB.1.5.
In consequence to a question about the origin of the presently noticeable interest in vaccines, Szuster-Ciesielska explained that people inactive receive information about the advanced number of cases of infections, including deaths associated with COVID-19.
– Especially those at hazard are afraid about their wellness in case of illness, especially as the last doses of vaccines were taken over a year ago. Hence they simply want to be safe erstwhile there is simply a anticipation – Said the virologist.
She noted that the available doses of the vaccine had already been exhausted on the first day, and that all available dates had been reserved, which in her opinion suggests that the number of doses ordered was insufficient.
– I successfully managed to registry right at the beginning via the Online Patient Account and I am already vaccinated. As far as I know, due to the deficiency of vaccines and waiting for another delivery, eager people were later recorded in the alleged notebook. In addition, the current evidence strategy is to be revised on 15 December. This may besides translate into difficulties in accessing vaccines – stressed the specialist.
She recommended choosing Nuvaxovid XBB during e-registration, due to the fact that she is the most fresh version of the vaccine.
– The another names of the products that appear concern vaccines against erstwhile coronavirus variants and their effectiveness is presently negligible: explained Prof. Szuster-Ciesielska.
She added that Novavax's latest vaccine is produced in protein technology, i.e. it already contains ready-made SARS-CoV-2 spike proteins. As she pointed out, this is simply a vaccine that anyone can take – whether it's his next or his first dose of COVID-19 vaccine.
– It works not only against the suboption of the XBB 1.5. coronavirus, but besides against another subvariants circulating at the moment. Since the end of August, the wave has not been driven by 1 dominant variant of the coronavirus, as it had previously been in the case of e.g. alpha, beta, delta. presently it is simply a mixture of various sub-variants, including XBB – said Szuster-Ciesielska, who became known for spreading Covid propaganda.
In her opinion, the precedence should be the vaccination of hazard groups, including seniors, chronic respiratory disease, diabetic patients, transplant recipients and healthcare professionals.
– The interest in vaccinations has exceeded everyone's expectations, but it seems that just not adequate doses have been ordered so far. I fishy this is due to the fear of wasting the vaccine if there are little willing. It is hard to foretell whether the enthusiasm of the public will shortly come to an end – just as after the first vaccines appeared at the beginning of the pandemic said Szuster-Ciesielska.
This is from
Szuster-Ciesielska encourages the usage of the product on Kraken. Now he's expected to regulation Pirola.:
